September 4, 2026 - Trends

Vibe Medicine Challenges Institutional Care

New look.
Artistic shot of a peptide bottle from System Labs
System Labs

Peptide platforms are betting the future of medicine starts with a sleek brand.

Pulse check. Per Deloitte, trust is the top reason consumers try new healthcare services, but how they define trustworthy is evolving as AI and digital tools shift expectations.

Nearly 40% of Gen Z have used DTC services, versus just 7% of baby boomers, with younger gens favoring transparency, convenience, and control.

HypebeastRx. Peptide players are leveraging rogue marketing to win the new consumer, who’s more inclined to DIY and has lower tolerance for UX friction.

Emulating Hims’ controversial Super Bowl strategy, YC’s RonanRx dropped a cheeky launch video announcing $78/month “Farm-to-Table” GLP-1s, while System Labs assembled a lore-heavy editorial division. Selling more like streetwear than healthcare, celeb-backed Superpower also offers peptides.

Takeaway: Longstanding frustration with slow-moving institutions triggered healthcare’s vibe medicine era. With trust up for grabs, crafty ads are drawing attention at an opportune moment.

Jasmina Breen
Jasmina Breen
Strategic intelligence for the future of health.

We break down how fitness, wellness, and healthcare are converging — and what it means for business, culture, and capital.

No thanks.